Early detection of transcatheter heart valve dysfunction

References

• Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–1011.
   PubMed Web of Science ®Google Scholar
• Otto CM, Prendergast B. Aortic-Valve Stenosis — from patients at risk to severe valve obstruction. N Engl J Med. 2014;371:744–756.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax J, et al. ESC/EACTS guidelines on the management of valvular heart disease. Eur Heart J. 2017;38:2739–2791.
   Web of Science ®Google Scholar
• Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706–1715.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695–1705.
   PubMed Web of Science ®Google Scholar
• Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8:162–172.
   PubMed Web of Science ®Google Scholar
• Brown JM, O’Brien SM, Wu C, et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the society of thoracic surgeons National database. J Thorac Cardiovasc Surg. 2009;137:82–90.
   Web of Science ®Google Scholar
• Brennan JM, Thomas L, Cohen DJ, et al. Transcatheter versus surgical aortic valve replacement. J Am Coll Cardiol. 2017;70:439–450.
   PubMed Web of Science ®Google Scholar
• Vogt PR, Brunner-LaRocca H-P, Sidler P, et al. Reoperative surgery for degenerated aortic bioprostheses: predictors for emergency surgery and reoperative mortality. Eur J Cardiothorac Surg. 2000;17:134–139.
   PubMed Web of Science ®Google Scholar
• Capodanno D, Petronio AS, Prendergast B, et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: A consensus statement from the European association of percutaneous cardiovascular interven. Eur Heart J. 2017;38:3382–3390.
   PubMed Web of Science ®Google Scholar
• Dvir D, Bourguignon T, Otto CM, et al. Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation. 2018;137:388–399.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC guideline for the management of patients with valvular heart disease: executive summary. Circulation. 2014;2014(129):2440–2492.
   Web of Science ®Google Scholar
• Ribeiro HB, Orwat S, Hayek SS, et al. Cardiovascular magnetic resonance to evaluate aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;68:577–585.
   PubMed Web of Science ®Google Scholar
• Chenot F, Montant P, Goffinet C, et al. Evaluation of anatomic valve opening and leaflet morphology in aortic valve bioprosthesis by using multidetector ct: comparison with transthoracic echocardiography. Radiology. 2010;255:377–385.
   PubMed Web of Science ®Google Scholar
• Tamburino C, Ussia GP. Percutaneous Treatment of left side cardiac valves. percutaneous treat. Left side card. Valves. Springer. 2012.
   Google Scholar
• Takagi H, Umemoto T. Prosthesis–patient mismatch after transcatheter aortic valve implantation. Ann Thorac Surg. 2016;101:872–880.
   PubMed Web of Science ®Google Scholar
• Abdelghani M, Allali A, Kaur J, et al. Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis–patient mismatch after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2019;93:971–979.
   PubMed Web of Science ®Google Scholar
• D’Ascenzo F, Salizzoni S, Saglietto A, et al. Incidence, predictors and cerebrovascular consequences of leaflet thrombosis after transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2019;56:488–494.
   PubMed Web of Science ®Google Scholar
• Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, et al. Infective endocarditis after transcatheter aortic valve implantation. Circulation. 2015;131:1566–1574.
   PubMed Web of Science ®Google Scholar
• Kim KM, Herrera GA, Battarbee HD. Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts. Am J Pathol. 1999;154:843–852.
   PubMed Web of Science ®Google Scholar
• Pibarot P, Dumesnil JG. Prosthetic Heart Valves. Circulation. 2009;119:1034–1048.
   PubMed Web of Science ®Google Scholar
• Sinning J-M, Vasa-Nicotera M, Chin D, et al. Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2013;62:11–20.
   PubMed Web of Science ®Google Scholar
• Sellers RD, Levy MJ, Amplatz K, et al. Left retrograde cardioangiography in acquired cardiac disease. Am J Cardiol. 1964;14:437–447.
   PubMed Web of Science ®Google Scholar
• Zoghbi WA, Chambers JB, Dumesnil JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound. J Am Soc Echocardiogr. 2009;22:975–1014.
   PubMed Web of Science ®Google Scholar
• Lancellotti P, Tribouilloy C, Hagendorff A, et al. European association of echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr. 2010;11:223–244.
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document. Eur Heart J. 2012;33:2403–2418.
   PubMed Web of Science ®Google Scholar
• Khalique OK, Hahn RT, Gada H, et al. Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2014;7:885–894.
   PubMed Web of Science ®Google Scholar
• Tuzcu EM, Kapadia SR, Svensson LG. Valve design and paravalvular aortic regurgitation. Circulation. 2014;129:1378–1380.
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;60:1438–1454.
   PubMed Web of Science ®Google Scholar
• Pibarot P, Hahn RT, Weissman NJ, et al. Assessment of paravalvular regurgitation following TAVR: A proposal of unifying grading scheme. JACC Cardiovasc Imaging. 2015;8:340–360.
   PubMed Web of Science ®Google Scholar
• Orwat S, Diller G-P, Kaleschke G, et al. Aortic regurgitation severity after transcatheter aortic valve implantation is underestimated by echocardiography compared with MRI. Heart. 2014;100:1933–1938.
   PubMed Web of Science ®Google Scholar
• Altiok E, Frick M, Meyer CG, et al. Comparison of two- and three-dimensional transthoracic echocardiography to cardiac magnetic resonance imaging for assessment of paravalvular regurgitation after transcatheter aortic valve implantation. Am J Cardiol. 2014;113:1859–1866.
   PubMed Web of Science ®Google Scholar
• Cawley PJ, Hamilton-Craig C, Owens DS, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging. 2013;6:48–57.
   PubMed Web of Science ®Google Scholar
• Harris AW, Krieger EV, Kim M, et al. Cardiac magnetic resonance imaging versus transthoracic echocardiography for prediction of outcomes in chronic aortic or mitral regurgitation. Am J Cardiol. 2017;119:1074–1081.
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab M, Abdelghani M, Miyazaki Y, et al. A novel angiographic quantification of aortic regurgitation after TAVR provides an accurate estimation of regurgitation fraction derived from cardiac magnetic resonance imaging. JACC Cardiovasc Interv. 2018;11:287–297.
   PubMed Web of Science ®Google Scholar
• Tateishi H, Campos CM, Abdelghani M, et al. Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry. EuroIntervention. 2016;11:1409–1418.
   PubMed Web of Science ®Google Scholar
• Schultz CJ, Slots TLB, Yong G, et al. An objective and reproducible method for quantification of aortic regurgitation after TAVI. EuroIntervention. 2014;10:355–363.
   PubMed Web of Science ®Google Scholar
• Pibarot P, Magne J, Leipsic J, et al. Imaging for predicting and assessing prosthesis-patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging. 2019;12:149–162.
   PubMed Web of Science ®Google Scholar
• Sokalskis V, Muraru D, Fraccaro C, et al. Echocardiographic follow-up after transcatheter aortic valve replacement. Echocardiography. 2017;34:267–278.
   PubMed Web of Science ®Google Scholar
• Lancellotti P, Pibarot P, Chambers J, et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European association of cardiovascular imaging endorsed by the Chinese society of echocardiography, the Inter-American society of echocardiography, and the Brazilian. Eur Hear J – Cardiovasc Imaging. 2016;17:589–590.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–2791.
   PubMed Web of Science ®Google Scholar
• Puls M, Eiffert H, Hünlich M, et al. Prosthetic valve endocarditis after transcatheter aortic valve implantation: the incidence in a single-centre cohort and reflections on clinical, echocardiographic and prognostic features. EuroIntervention. 2013;8:1407–1418.
   PubMed Web of Science ®Google Scholar
• Lee HS, Lee S-P, Jung J-H, et al. Infective endocarditis associated with transcatheter aortic valve replacement: potential importance of local trauma for a deadly nidus. J Cardiovasc Ultrasound. 2014;22:134.
   PubMedGoogle Scholar
• Sinning JM, Hammerstingl C, Chin D, et al. Decrease of pulmonary hypertension impacts on prognosis after transcatheter aortic valve replacement. EuroIntervention. 2014;9:1042–1049.
   Web of Science ®Google Scholar
• Szymański P, Hryniewiecki T, Dąbrowski M, et al. Mitral and aortic regurgitation following transcatheter aortic valve replacement. Heart. 2016;102:701–706.
   PubMed Web of Science ®Google Scholar
• Perlman GY, Loncar S, Pollak A, et al. Post-procedural hypertension following transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2013;6:472–478.
   PubMed Web of Science ®Google Scholar
• Yotti R, Bermejo J, Gutiérrez-Ibañes E, et al. Systemic vascular load in calcific degenerative aortic valve stenosis. J Am Coll Cardiol. 2015;65:423–433.
   PubMed Web of Science ®Google Scholar
• Eisen A, Shapira Y, Sagie A, et al. Infective endocarditis in the transcatheter aortic valve replacement era: comprehensive review of a rare complication. Clin Cardiol. 2012;35:E1–E5.
   PubMed Web of Science ®Google Scholar
• Marwan M, Mekkhala N, Göller M, et al. Leaflet thrombosis following transcatheter aortic valve implantation. J Cardiovasc Comput Tomogr. 2018;12:8–13.
   PubMed Web of Science ®Google Scholar
• Soschynski M, Capilli F, Ruile P, et al. Post-TAVI follow-up with MDCT of the valve prosthesis: technical application, regular findings and typical local post-interventional complications. RöFo - Fortschritte Auf Dem Gebiet Der Röntgenstrahlen Und Der Bildgeb Verfahren. 2018;190:521–530.
   Web of Science ®Google Scholar
• Dangas GD, Weitz JI, Giustino G, et al. Prosthetic heart valve thrombosis. J Am Coll Cardiol. 2016;68:2670–2689.
   Web of Science ®Google Scholar
• Rashid HN, Brown AJ, McCormick LM, et al. Subclinical leaflet thrombosis in transcatheter aortic valve replacement detected by multidetector computed tomography ― a review of current evidence. Circ J. 2018;82:1735–1742.
   Web of Science ®Google Scholar
• Mahjoub H, Mathieu P, Sénéchal M, et al. ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration. J Am Coll Cardiol. 2013;61:752–761.
   PubMed Web of Science ®Google Scholar
• Mahjoub H, Mathieu P, Larose E, et al. Determinants of aortic bioprosthetic valve calcification assessed by multidetector CT. Heart. 2015;101:472–477.
   PubMed Web of Science ®Google Scholar
• Mylotte D, Andalib A, Theriault-Lauzier P, et al. Transcatheter heart valve failure: a systematic review. Eur Heart J. 2015;36:1306–1327.
   PubMed Web of Science ®Google Scholar
• Mazine A, Verma S, Yanagawa B. Early failure of aortic bioprostheses. Curr Opin Cardiol. 2019;34:173–177.
   PubMed Web of Science ®Google Scholar
• Rosseel L, De Backer O, Søndergaard L. Clinical valve thrombosis and subclinical leaflet thrombosis in transcatheter aortic heart valves: clinical manifestations, diagnosis, and treatment. Precis Clin Med. 2018;1:111–117.
   Google Scholar
• Jilaihawi H, Asch FM, Manasse E, et al. Systematic CT methodology for the evaluation of subclinical leaflet thrombosis. JACC Cardiovasc Imaging. 2017;10:461–470.
   PubMed Web of Science ®Google Scholar
• Makkar RR, Fontana G, Jilaihawi H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373:2015–2024.
   PubMed Web of Science ®Google Scholar
• Sondergaard L, De Backer O, Kofoed KF, et al. Natural history of subclinical leaflet thrombosis affectingmotion in bioprosthetic aortic valves. Eur Heart J. 2017;38:2201–2207.
   Web of Science ®Google Scholar
• Hansson NC, Grove EL, Andersen HR, et al. Transcatheter aortic valve thrombosis. J Am Coll Cardiol. 2016;68:2059–2069.
   PubMed Web of Science ®Google Scholar
• Chakravarty T, Søndergaard L, Friedman J, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017;389:2383–2392.
   PubMed Web of Science ®Google Scholar
• Leetmaa T, Hansson NC, Leipsic J, et al. Early aortic transcatheter heart valve thrombosis. Circ Cardiovasc Interv. 2015;8.
   Web of Science ®Google Scholar
• Pache G, Schoechlin S, Blanke P, et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur Heart J. 2016;37:2263–2271.
   PubMed Web of Science ®Google Scholar
• Yahagi K, Torii S, Ladich E, et al. Pathology of self-expanding transcatheter aortic valves: findings from the CoreValve US pivotal trials. Catheter Cardiovasc Interv. 2018;91:947–955.
   PubMed Web of Science ®Google Scholar
• Sondergaard L, De Backer O, Kofoed KF, et al. Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves. Eur Heart J. 2017;38:2201–2207.
   PubMed Web of Science ®Google Scholar
• Kanjanauthai S, Pirelli L, Nalluri N, et al. Subclinical leaflet thrombosis following transcatheter aortic valve replacement. J Interv Cardiol. 2018;31:640–647.
   PubMed Web of Science ®Google Scholar
• Ruile P, Minners J, Breitbart P, et al. Medium-term follow-up of early leaflet thrombosis after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:1164–1171.
   PubMedGoogle Scholar
• Rosseel L, De Backer O, Søndergaard L. clinical valve thrombosis and subclinical leaflet thrombosis following transcatheter aortic valve replacement: is there a need for a patient-tailored antithrombotic therapy? Front Cardiovasc Med. 2019;6:44.
   Web of Science ®Google Scholar
• Jose J, Sulimov DS, El-Mawardy M, et al. Clinical bioprosthetic heart valve thrombosis after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2017;10:686–697.
   PubMed Web of Science ®Google Scholar
• Rogers T, Waksman R. Role of CMR in TAVR. JACC Cardiovasc Imaging. 2016;9:593–602.
   PubMed Web of Science ®Google Scholar
• Crouch G, Tully PJ, Bennetts J, et al. Quantitative assessment of paravalvular regurgitation following transcatheter aortic valve replacement. J Cardiovasc Magn Reson. 2015;17:32.
   PubMed Web of Science ®Google Scholar
• Hartlage GR, Babaliaros VC, Thourani VH, et al. The role of cardiovascular magnetic resonance in stratifying paravalvular leak severity after transcatheter aortic valve replacement: an observational outcome study. J Cardiovasc Magn Reson. 2014;16:93.
   PubMed Web of Science ®Google Scholar
• Forsythe RO, Dweck MR, McBride OMB, et al. 18 F–sodium fluoride uptake in abdominal aortic aneurysms. J Am Coll Cardiol. 2018;71:513–523.
   PubMed Web of Science ®Google Scholar
• Irkle A, Vesey AT, Lewis DY, et al. Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography. Nat Commun. 2015;6:7495.
   PubMed Web of Science ®Google Scholar
• Dweck MR, Chow MWL, Joshi NV, et al. Coronary arterial 18F-sodium fluoride uptake. J Am Coll Cardiol. 2012;59:1539–1548.
   PubMed Web of Science ®Google Scholar
• Kitagawa T, Yamamoto H, Nakamoto Y, et al. Predictive value of 18 F‐Sodium fluoride positron emission tomography in detecting high‐risk coronary artery disease in combination with computed tomography. J Am Heart Assoc. 2018;7.
   Web of Science ®Google Scholar
• Kim J-M, Lee ES, Park K-Y, et al. Comparison of [18F]-FDG and [18F]-NaF positron emission tomography on culprit carotid atherosclerosis. JACC Cardiovasc Imaging. 2019;12:370–372.
   PubMed Web of Science ®Google Scholar
• Dweck MR, Jenkins WSA, Vesey AT, et al. 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging. 2014;7:371–378.
   PubMed Web of Science ®Google Scholar
• Dweck MR, Jones C, Joshi NV, et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation. 2012;125:76–86.
   PubMed Web of Science ®Google Scholar
• Jenkins WSA, Vesey AT, Shah ASV, et al. Valvular 18F-fluoride and 18F-fluorodeoxyglucose uptake predict disease progression and clinical outcome in patients with aortic stenosis. J Am Coll Cardiol. 2015;66:1200–1201.
   PubMed Web of Science ®Google Scholar
• Cartlidge TRG, Doris MK, Sellers SL, et al. Detection and prediction of bioprosthetic aortic valve degeneration. J Am Coll Cardiol. 2019;73:1107–1119.
   PubMed Web of Science ®Google Scholar